Rapidly Progressing Prostate Cancer With Low Prostate-Specific Antigen and Gleason Score 5+5: A Case Report
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This case highlights a rare, aggressive prostate cancer with a low PSA level. Standard treatments like androgen deprivation and radiotherapy proved insufficient, indicating a need for novel therapeutic approaches.
Area Of Science
- Oncology
- Urology
- Medical Oncology
Background
- Advanced prostate cancer (T4N1M0) in an elderly male presented with severe urinary dysfunction and retention.
- Initial prostate-specific antigen (PSA) was 1.23 ng/mL, with biopsy confirming Gleason 5+5 adenocarcinoma.
Observation
- The patient received androgen deprivation therapy and whole-pelvic radiotherapy (80 Gy).
- A nadir PSA of 0.40 ng/mL was followed by a rapid increase to 35.92 ng/mL.
- Metastasis to the corpus cavernosum penis occurred, resulting in malignant priapism.
Findings
- High-grade prostate cancer with low initial PSA is exceptionally aggressive and challenging to treat.
- Standard treatment modalities (androgen deprivation therapy and radiotherapy) demonstrated limited efficacy in this advanced case.
- Rapid disease progression and metastasis occurred despite initial therapeutic interventions.
Implications
- This case underscores the limitations of current treatment strategies for rare, aggressive prostate cancer subtypes.
- There is a critical need for developing and investigating more effective therapeutic options for such advanced and rapidly progressing malignancies.
- Further research into novel treatment combinations or targeted therapies is essential for improving outcomes in these challenging cases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...